A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes

CONTEXT: There is a medical need for effective insulin-independent antidiabetic drugs that can promote pancreatic β-cell function and have a low risk of hypoglycemia in type 2 diabetes mellitus (T2DM) patients. R-form verapamil (R-Vera), which is able to enhance the survival of β-cells and has highe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chih-Yuan, Huang, Kuo-Chin, Lu, Chia-Wen, Chu, Chih-Hsun, Huang, Chien-Ning, Chen, Harn-Shen, Lee, I-Te, Chen, Jung-Fu, Chen, Ching-Chu, Chen, Chung-Sen, Hsieh, Chang-Hsun, Tien, Kai-Jen, Chien, Hung-Yu, Huang, Yu-Yao, Hsu, Jui-Pao, Shane, Guang-Tzuu, Chang, Ai-Ching, Wu, Yen-Chieh, Sheu, Wayne Huey-Herng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516171/
https://www.ncbi.nlm.nih.gov/pubmed/35917580
http://dx.doi.org/10.1210/clinem/dgac436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516171/
https://www.ncbi.nlm.nih.gov/pubmed/35917580
http://dx.doi.org/10.1210/clinem/dgac436

Ejemplares similares